Highlights Penumbra, Inc.

Equities

PEN

US70975L1070

Real-time Estimate Cboe BZX Other stock markets 12:36:06 2024-05-09 pm EDT			5-day change	1st Jan Change
208.3 ^USD	+2.57%		+1.25%	-17.05%

May. 08	Morgan Stanley Cuts Price Target on Penumbra to $235 From $240, Keeps Equalweight Rating	MT
May. 07	Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Penumbra Q1 Non-GAAP EPS, Revenue Increase; Reaffirms 2024 Revenue Outlook	May. 07	MT
Earnings Flash (PEN) PENUMBRA Reports Q1 Revenue $278.7M, vs. Street Est of $274.5M	May. 07	MT
Earnings Flash (PEN) PENUMBRA Reports Q1 EPS $0.41, vs. Street Est of $0.38	May. 07	MT
Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024	May. 07	CI
Penumbra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots	Apr. 23	CI
DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment	Apr. 17	MT
Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate	Mar. 27	MT
North American Morning Briefing : Traders Await -2-	Feb. 26	DJ
Penumbra Q4 Non-GAAP EPS, Revenue Increase; Shares Fall After-Hours	Feb. 22	MT
Earnings Flash (PEN) PENUMBRA Posts Q4 Revenue $284.7M, vs. Street Est of $286.5M	Feb. 22	MT
Earnings Flash (PEN) PENUMBRA Reports Q4 EPS $0.76, vs. Street Est of $0.70	Feb. 22	MT
Penumbra, Inc. Provides Earnings Guidance for the Full Year 2024	Feb. 22	CI
Penumbra, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Penumbra, Inc. Announces First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash for Treatment of Acute Pulmonary Embolism	Nov. 28	CI
Penumbra's Q3 Non-GAAP Earnings, Revenue Rise	Nov. 03	MT
Earnings Flash (PEN) PENUMBRA Posts Q3 Revenue $270.9M, vs. Street Est of $265.1M	Nov. 02	MT
Earnings Flash (PEN) PENUMBRA Reports Q3 EPS $0.67, vs. Street Est of $0.45	Nov. 02	MT
Penumbra, Inc. Provides Earnings Guidance for the Full Year 2023	Nov. 02	CI
Penumbra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Penumbra, Inc. : The underdog in healthcare

April 11, 2024 at 09:39 pm EDT